Chest Drainage Catheters Market By Product Type (Traditional Chest Tubes, Pigtail Catheters, Secure-Drain Systems); By Application (Thoracic Surgery, Trauma Management, Oncology-Related Pleural Effusions, Cardiac Surgery, Infectious and Inflammatory Conditions); By End User (Hospitals and Trauma Centers, Ambulatory Surgical Centers, Oncology Clinics, Military and Field Hospitals); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Chest Drainage Catheters Market: How Are Minimally Invasive Drainage and Outpatient Pleural Care Shaping Growth? – (Updated On: 20th-Oct-2026)

The Global Chest Drainage Catheters Market was valued at USD 689.99 million in 2025 and is projected to reach USD 1,047.95 million by 2032, growing at a CAGR of approximately 6.15%, according to Strategic Market Research. Demand is driven by pleural diseases, lung cancer complications, pneumothorax, and thoracic surgical procedures requiring effective removal of air or fluid from the pleural cavity.

 

Pleural effusion represents a major source of clinical demand. According to the American Academy of Family Physicians, approximately 1.5 million people experience pleural effusion annually in the United States, with around 173,000 undergoing thoracentesis. Malignant pleural effusion adds an estimated 150,000 new cases and 125,000 related hospitalizations annually, supporting demand for indwelling pleural catheters and repeated drainage procedures. Not all these cases require chest drainage catheters, but they illustrate the scale of relevant clinical needs. (Clinical Review)

 

Thoracic surgery and emergency care provide additional demand. The Society of Thoracic Surgeons' General Thoracic Surgery Database recorded 38,331 procedural records in 2024 across participating centers. Chest drainage catheters remain important in postoperative recovery and the management of pneumothorax, hemothorax, and empyema. (STS Annual Update)

 

Advances in minimally invasive drainage and digital monitoring are improving treatment options. BD's PleurX system supports long-term pleural fluid management at home, while Medela's Thopaz+ provides digital air-leak monitoring and regulated suction for postoperative care. These technologies reflect growing interest in outpatient treatment, patient comfort, and more consistent drainage monitoring.

 

Growth through 2032 will be supported by thoracic procedures, long-term pleural disease management, and adoption of advanced drainage technologies. Infection prevention, procedural safety, and treatment costs will remain important considerations for healthcare providers.

 

Which Subsegments Are Leading the Chest Drainage Catheters Market and Emerging as Key Opportunities?

By Product Type: Traditional Chest Tubes Lead While Pigtail Catheters Gain Momentum

Leading Subsegment – Traditional Chest Tubes

Traditional chest tubes dominated the Chest Drainage Catheters Market with an estimated 46% share, equivalent to USD 317.40 million in 2025, and are projected to expand at a CAGR of 4.97% during 2026–2032. Their established clinical role involves large-caliber thoracostomy drainage for rapid removal of air, blood, pus, and thick pleural fluids. Widespread utilization in trauma management, thoracic surgeries, hemothorax treatment, and complicated pleural infections supports their strong market position, particularly across hospitals and emergency care settings worldwide.

Fastest-Growing Subsegment – Pigtail Catheters

Pigtail catheters accounted for approximately 32% of the global Chest Drainage Catheters Market, representing an estimated USD 220.80 million in 2025, with a projected CAGR of 8.14% during 2026–2032. Typically ranging from 8Fr to 14Fr, pigtail catheters offer a minimally invasive alternative to conventional large-bore chest tubes measuring 16Fr to 32Fr. Their growing clinical utilization in managing pneumothorax and pleural effusions is supported by reduced insertion trauma, improved patient comfort, and suitability for image-guided drainage procedures across hospitals and emergency care settings.

 

By Application: Thoracic Surgery Dominates While Oncology-Related Drainage Expands

Leading Subsegment – Thoracic Surgery

Thoracic surgery accounted for approximately 34% of the global Chest Drainage Catheters Market, representing USD 234.60 million in 2025, with an estimated CAGR of 5.24% during 2026–2032. Chest drainage catheters are widely used following lung resections, thoracic trauma procedures, and pleural interventions to remove accumulated air, blood, and fluid from pleural and mediastinal spaces. Their clinical importance lies in restoring negative intrathoracic pressure, facilitating lung re-expansion, and supporting postoperative respiratory recovery while reducing complications associated with fluid accumulation and pneumothorax.

Fastest-Growing Subsegment – Oncology-Related Pleural Effusions

Oncology-related pleural effusions account for approximately 21% of the global Chest Drainage Catheters Market, representing an estimated USD 144.90 million in 2025, with a projected CAGR of 9.49% during 2026–2032. Malignant pleural effusions commonly occur in patients with lung cancer, breast cancer, or lymphoma when tumor involvement obstructs pleural fluid drainage, causing fluid accumulation and severe breathlessness. Recurrent fluid buildup supports the clinical utilization of indwelling pleural catheters, enabling repeated drainage, symptom relief, and outpatient palliative care management for cancer patients.

 

By End User: Hospitals Maintain Leadership While Oncology Clinics Expand

Leading Subsegment – Hospitals and Trauma Centers

Hospitals and trauma centers dominate the Chest Drainage Catheters Market, accounting for approximately 64% of the global market, equivalent to USD 441.59 million in 2025, with a projected CAGR of 5.51% during 2026–2032. Their leading position reflects the high volume of emergency chest trauma cases, pneumothorax management, and pleural drainage procedures performed in hospital settings. Designated trauma centers provide rapid diagnosis, chest tube and pigtail catheter placement, surgical intervention, and intensive monitoring, supporting consistent catheter utilization across emergency departments and critical care units.

Fastest-Growing Subsegment – Oncology Clinics

Oncology clinics represent approximately 14% market share, equivalent to an estimated USD 96.60 million in 2025 revenue, with an illustrative CAGR of 8.68% during 2026–2032. Increasing adoption of long-term indwelling pleural catheters, outpatient cancer treatment, and home-based drainage programs supports expansion. These settings emphasize patient comfort, repeated effusion management, and reduced hospitalization.

 

By Geography: The United States Leads While Asia-Pacific Advances

Leading Subsegment – United States

The United States holds approximately 31% of the global Chest Drainage Catheters Market, valued at USD 213.90 million in 2025, with a projected CAGR of 5.40% through 2032. Market expansion is supported by the widespread use of chest drainage catheters in cardiothoracic surgeries, emergency trauma care, and pleural effusion management. Increasing surgical interventions, lung cancer cases, and hospital admissions involving pneumothorax contribute to catheter utilization. Advanced drainage technologies and established thoracic surgery infrastructure further strengthen the country's position in the global market.

Fastest-Growing Subsegment – Asia-Pacific

Asia-Pacific accounted for approximately 17% of the global Chest Drainage Catheters Market, contributing an estimated USD 117.30 million in 2025, with a projected CAGR of 6.98% through 2032. Regional expansion is supported by increasing thoracic surgical procedures, trauma-related hospital admissions, and the treatment of pleural effusion and pneumothorax. China, India, and Japan are strengthening thoracic care capabilities through hospital infrastructure investments and improved access to minimally invasive procedures. Wider availability of small-bore drainage catheters and image-guided catheter placement further supports clinical adoption across healthcare facilities.

 

Which Companies Are Leading the Chest Drainage Catheters Market and What Technologies Define Their Competitive Positions?

Leading Companies and Their Technological Contributions

Becton, Dickinson and Company (BD) — Advancing Long-Term Pleural Drainage

BD is a prominent participant in pleural drainage technology, particularly through its PleurX Pleural Catheter System, designed for patients experiencing recurrent pleural effusions, including malignant effusions associated with cancer. The system uses a tunneled catheter and vacuum-assisted collection bottles to facilitate intermittent drainage outside conventional inpatient settings.

BD offers a 1,000 mL vacuum drainage bottle, enabling controlled fluid collection. The PleurX system supports symptom management and home-based pleural care, reducing the need for repeated hospital drainage procedures in appropriately selected patients.

Medela — Strengthening Digital Chest Drainage Monitoring

Medela specializes in advanced thoracic drainage management through its Thopaz+ Digital Chest Drainage and Monitoring System. The technology incorporates continuous air-leak measurement, regulated suction, real-time pressure monitoring, and digital fluid-output tracking to support postoperative recovery decisions.

According to Medela, its digital drainage technology has accumulated experience across more than 2 million cases, including over 100,000 cardiac cases, and is supported by more than 40 studies. The system offers disposable collection canisters of 300 mL, 800 mL, and 2 liters, enabling clinical flexibility in thoracic and cardiac surgery settings.

These examples demonstrate technological relevance rather than a verified ranking by chest drainage catheter revenue or market share; comparable company-specific market shares are not publicly established here.

Other Key Companies and Their Roles

• Teleflex Incorporated: Offers Arrow Pneumothorax Kits, Arrow-Clarke Thoracentesis Catheters, and Blue FlexTip drainage technologies for pleural access and minimally invasive drainage.

• Cook Medical: Supplies interventional drainage catheters and access devices used in image-guided fluid collection and thoracic interventions.

• Medtronic: Supports cardiothoracic surgical care through instruments and technologies used in procedures that may require postoperative chest drainage.

• Getinge AB: Provides cardiothoracic surgical technologies and hospital equipment supporting complex postoperative patient management.

• Cardinal Health: Contributes medical-surgical supplies and distribution capabilities supporting hospital drainage procedures and consumable availability.

• ICU Medical: Specializes in fluid-management and critical-care devices, with an adjacent role in intensive care environments where chest drainage is performed.

• Redax: Develops thoracic drainage systems, chest drains, and related collection devices for surgical and pleural fluid management.

 

What Are the Key Factors Driving the Global Chest Drainage Catheters Market?

Rising Prevalence of Respiratory Diseases and Lung Cancer

The increasing incidence of lung cancer, chronic obstructive pulmonary disease (COPD), pneumonia, and pleural disorders is a major driver of the chest drainage catheters market. According to the World Health Organization, lung cancer accounted for approximately 2.5 million new cases and 1.8 million deaths globally in 2022. Advanced lung cancer and other malignancies can cause pleural effusions, requiring therapeutic drainage to relieve breathlessness and improve patient comfort. The substantial burden of respiratory diseases supports continued use of chest drainage procedures.

Increasing Cardiothoracic Surgical Procedures

The rising number of lung resections, lobectomies, thoracotomies, and cardiac surgeries contributes significantly to chest drainage catheter utilization. These devices are commonly used after surgical procedures to remove accumulated blood, air, and fluid from the thoracic cavity. Increasing access to specialized cardiac and thoracic surgical services, particularly in developing healthcare markets, supports the need for reliable postoperative drainage solutions.

Greater Adoption of Minimally Invasive Drainage Technologies

Healthcare providers are increasingly adopting small-bore pigtail catheters and image-guided drainage techniques as alternatives to conventional large-bore chest tubes for selected clinical conditions. Small-bore catheters, typically 14 French or smaller, can reduce insertion-related discomfort and facilitate less invasive pleural interventions. Their suitability for certain pneumothorax cases and pleural effusions encourages wider utilization across hospitals and outpatient treatment facilities.

Technological Advancements in Digital Drainage Systems

Innovations in digital chest drainage monitoring, regulated suction, and medical-grade catheter materials are improving device functionality and clinical decision-making. Systems such as Medela's Thopaz+ enable continuous monitoring of air leaks and drainage activity, helping clinicians assess recovery and determine appropriate catheter removal. Improvements in silicone and polyurethane designs also promote catheter flexibility and reduce mechanical complications such as kinking.

Expanding Homecare and Outpatient Pleural Drainage

The increasing preference for home-based management of recurrent pleural effusions is creating opportunities for indwelling pleural catheters. BD's PleurX Pleural Catheter System incorporates vacuum-assisted drainage technology and allows appropriately trained patients or caregivers to manage recurrent fluid accumulation at home. This approach can reduce repeated hospital visits and support patient independence, particularly in palliative oncology care.

Rising Thoracic Trauma and Emergency Care Requirements

Chest injuries associated with road traffic accidents, falls, and penetrating trauma remain an important source of clinical need for drainage catheters. Traumatic pneumothorax and hemothorax may require urgent intervention to prevent respiratory deterioration. Continued investment in emergency departments, trauma centers, and critical-care infrastructure supports access to chest drainage procedures, particularly in regions expanding their emergency medical capabilities.

Aging Population and Increasing Healthcare Accessibility

Population aging contributes to a higher burden of cancer, cardiovascular disease, and other conditions that may require thoracic intervention. At the same time, expansion of specialized hospitals, surgical facilities, and diagnostic imaging services improves access to pleural drainage procedures. These developments support adoption of both conventional chest tubes and advanced catheter technologies across established and emerging healthcare systems.

 

Analyst Commentary: How Will Small-Bore Catheters and Digital Monitoring Shape Pleural Care?

The chest drainage catheters market is undergoing a significant technological shift toward minimally invasive pleural interventions, intelligent drainage monitoring, and patient-centered respiratory care. The strongest opportunities lie in next-generation small-bore pigtail catheters, digitally controlled suction systems, real-time air-leak detection, and tunneled pleural catheters for long-term home management. Increasing emphasis on enhanced recovery after thoracic surgery, reducing hospitalization, and improving procedural safety is accelerating the transition toward more efficient drainage solutions. Future innovations in biocompatible materials, automated monitoring, and outpatient pleural care are expected to redefine clinical practices and improve treatment efficiency.

 

Chest Drainage Catheters Market Report Coverage Table

Report Attribute	Details
Forecast Period	2026 – 2032
Market Size Value in 2025	USD 689.99 Million
Revenue Forecast in 2032	USD 1,047.95 Million
Overall Growth Rate	CAGR of 6.15% (2026 – 2032)
Base Year for Estimation	2025
Historical Data	2019 – 2024
Unit	USD Million, CAGR (2026 – 2032)
Segmentation	By Product Type, By Application, By End User, By Geography
By Product Type	Traditional Chest Tubes, Pigtail Catheters, Secure-Drain Systems
By Application	Thoracic Surgery, Trauma Management, Oncology-Related Pleural Effusions, Cardiac Surgery, Infectious and Inflammatory Conditions
By End User	Hospitals and Trauma Centers, Ambulatory Surgical Centers, Oncology Clinics, Military and Field Hospitals
By Geography	North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Country Scope	U.S., Canada, UK, Germany, France, Italy, Spain, China, Japan, South Korea, India, Australia, Brazil, Mexico, Saudi Arabia, UAE, South Africa
Market Drivers	Thoracic and cardiac surgical drainage requirements, recurrent malignant pleural effusion management, adoption of small-bore pigtail catheters, expanding outpatient and home-based pleural drainage, trauma and emergency-care requirements
Customization Option	Available upon request